WX [WuXi PharmaTech (Cayman)] 6-K: Form 6-K TABLE OF CONTENTS Page 3 4
[Form 6-K TABLE OF CONTENTS Page 3 4]
EVK [Ever-Glory International,] 10-Q: (Original Filing)
[EVER-GLORY INTERNATIONAL, FORM10-Q INDEX Page Number PART I. FINANCIAL INFORMATION 4 Item 1. Financial Statements 4ndensednsolidated Balance Sheets of September 30, 2010 (unaudited) and December 31, 2009 4ndensednsolidated Statements of Operations andmprehensiveome for the Three and Nine Months Ended September 30, 2010 and 2009 (unaudited)] [I, Edward Yihua Kang, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ending September 30, 2010 of Ever-Glory International,; 2. Based The Designed such internalntrol over financial reporting, orused such internalntrol over financial reporting to be designed under our supervision, to provide reasonablesurance regarding the reliability of financial] [I, Jiansong Wang, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ending September 30, 2010 of Ever-Glory International,; 2. Based 3. 4. The a. b. Designed such internalntrol over financial reporting, orused such internalntrol over financial reporting to be designed under our supervision, to provide reasonablesurance regarding the] [Section 906 ofrbanes-Oxley Act of 2002 1. 2. The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. Edward Yihua Kang Chief Executive Officer EX-32.1 v201907_ex32-1.htm 4 EX-32.1] [Section 906 ofrbanes-Oxley Act of 2002 1. 2. The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. Jiansong Wang Chief Finance Officer (Principal Finance Officer) EX-32.2 v201907_ex32-2.htm 5 EX-32.2]
HSOL [Hanwha Q CELLS] 6-K: (Original Filing)
[SOLARFUN POWER HOLDINGS CO., LTD. 8,000,000 American Depositary Shares Each representing five Ordinary Shares (par value US$0.0001 per share) UNDERWRITING AGREEMENT November 10, 2010 November 10, 2010 Morgan Stanley & Co. International plc UBS Securities LLC As the Managers for the Underwriters named in Schedule I hereto Ladies and Gentlemen: Company Underwriters Managers Firm ADSs Additional ADSs ADSs Shares Ordinary] [Subscription Agreement THIS SUBSCRIPTION AGREEMENT (this Agreement) is made as of November 9, 2010, by and between Solarfun Power Holdings Co., Ltd., an exempted company incorporated and validly existing with limited liability under the laws of Cayman Islands (the Company), and Hanwha Solar Holdings Co., Ltd., an exempted company incorporated and validly existing with limited liability under the laws of] [FORM 6-K SOLARFUN POWER HOLDINGS CO., LTD. 888 Linyang Road þ o Form 20-F o þ Yes o þ Yes o þ Yes TABLE OF CONTENTS EX-99.1 EX-99.2 Solarfun Power Holdings Co., Ltd. (the Company) is furnishing under the cover of Form 6-K: 99.1 Underwriting Agreement by and among the Company, Morgan Stanley & Co. International plc and UBS Securities]
CXDC [China XD Plastics Co] 10-Q: (Original Filing)
[CHINA XD PLASTICS COMPANY LIMITED Index PART I— FINANCIAL INFORMATION Page Item 1. Financial Statements 2 Condensed Consolidated Financial Statements (Unaudited) 2 Notes to the Condensed Consolidated Financial Statements (unaudited) 5 Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 37 Item 3. Quantitative and Qualitative Disclosures About Market Risk 44 Item 4T. Controls and Procedures] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER 1. I have reviewed this quarterly report on Form 10-Q of China XD Plastics Company Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, Taylor Zhang, Chief Financial Officer (Principal Accounting and Financial Officer) of China XD Plastics Company Limited, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China XD Plastics Company Limited; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER 18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of China XD Plastics Company Limited. Dated: November 12, 2010 Jie Han Chairman of the Board and Chief Executive Officer] [CERTIFICATION OF CHIEF FINANCIAL OFFICER 18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of China XD Plastics Company Limited. Dated: November 12, 2010 Taylor Zhang Chief Financial Officer (Principal Accounting and Financial Officer)]
WX [WuXi PharmaTech (Cayman)] 6-K: (Original Filing)
[WuXi PharmaTech (Cayman) Inc. Form 6-K Page 3 4]
EVK [Ever-Glory International,] 10-Q: EVER-GLORY INTERNATIONAL, FORM10-Q INDEX Page Number PART I.
[EVER-GLORY INTERNATIONAL, FORM10-Q INDEX Page Number PART I. FINANCIAL INFORMATION 4 Item 1. Financial Statements 4ndensednsolidated Balance Sheets of September 30, 2010 (unaudited) and December 31, 2009 4ndensednsolidated Statements of Operations andmprehensiveome for the Three and Nine Months Ended September 30, 2010 and 2009 (unaudited)] [I, Edward Yihua Kang, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ending September 30, 2010 of Ever-Glory International,; 2. Based The Designed such internalntrol over financial reporting, orused such internalntrol over financial reporting to be designed under our supervision, to provide reasonablesurance regarding the reliability of financial] [I, Jiansong Wang, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ending September 30, 2010 of Ever-Glory International,; 2. Based 3. 4. The a. b. Designed such internalntrol over financial reporting, orused such internalntrol over financial reporting to be designed under our supervision, to provide reasonablesurance regarding the] [Section 906 ofrbanes-Oxley Act of 2002 1. 2. The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. Edward Yihua Kang Chief Executive Officer EX-32.1 v201907_ex32-1.htm 4 EX-32.1] [Section 906 ofrbanes-Oxley Act of 2002 1. 2. The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. Jiansong Wang Chief Finance Officer (Principal Finance Officer) EX-32.2 v201907_ex32-2.htm 5 EX-32.2]
HSOL [Hanwha Q CELLS] 6-K: SOLARFUN POWER HOLDINGS CO., LTD. 8,000,000 American Depositary
[SOLARFUN POWER HOLDINGS CO., LTD. 8,000,000 American Depositary Shares Each representing five Ordinary Shares (par value US$0.0001 per share) UNDERWRITING AGREEMENT November 10, 2010 November 10, 2010 Morgan Stanley & Co. International plc UBS Securities LLC As the Managers for the Underwriters named in Schedule I hereto Ladies and Gentlemen: Company Underwriters Managers Firm ADSs Additional ADSs ADSs Shares Ordinary] [Subscription Agreement THIS SUBSCRIPTION AGREEMENT (this Agreement) is made as of November 9, 2010, by and between Solarfun Power Holdings Co., Ltd., an exempted company incorporated and validly existing with limited liability under the laws of Cayman Islands (the Company), and Hanwha Solar Holdings Co., Ltd., an exempted company incorporated and validly existing with limited liability under the laws of] [FORM 6-K SOLARFUN POWER HOLDINGS CO., LTD. 888 Linyang Road þ o Form 20-F o þ Yes o þ Yes o þ Yes TABLE OF CONTENTS EX-99.1 EX-99.2 Solarfun Power Holdings Co., Ltd. (the Company) is furnishing under the cover of Form 6-K: 99.1 Underwriting Agreement by and among the Company, Morgan Stanley & Co. International plc and UBS Securities]
TPI [TIANYIN PHARMACEUTICAL] 10-Q: (Original Filing)
[FORM 10-Q (Mark One) For the quarterly period ended September 30, 2010 For the transition period from _______________ to _______________ Tianyin Pharmaceutical Co., Inc. Delaware (State or other jurisdiction of incorporation or organization) 23rd Floor, Unionsun Yangkuo Plaza No. 2, Block 3, Renmin Road South Chengdu, P. R. China, 610041 +0086-028-86154737 (Address, including zip code, and telephone number, Large Accelerated] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang certify that: 1. I have reviewed this quarterly report on Form 10-Q of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, James Jiayuan Tong, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2)T he information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Chief Executive Officer & Chairman EX-32.1 4 ex32one.htm CERTIFICATION] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. James Jiayuan Tong Chief Financial Officer, Chief Accounting Officer, Chief Business and Development Officer, Director EX-32.2 5]
WX [WuXi PharmaTech (Cayman)] 6-K: WuXi PharmaTech (Cayman) Inc. Form 6-K Page 3
[WuXi PharmaTech (Cayman) Inc. Form 6-K Page 3 4]
BSPM [Biostar Pharmaceuticals,] 10-Q: (Original Filing)
[FORM 10-Q (Mark One) x September 30, 2010 For the quarterly period ended: Or For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, Maryland 20-8747899 (State or other jurisdiction oforporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province Peoples Republic of China] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this quarterly 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with] [CERTIFICATION I, Deyin Chen, certify that: 1. I have reviewed this quarterly 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with] [CERTIFICATION (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. ex32-1.htm 4 EX-32.1] [CERTIFICATION (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. ex32-2.htm 5 EX-32.2]
